Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuti

Showing results (371-380 of 596) with videos related to

Pageof 60
Sort By:
Paediatric Drugs|August 30, 2008
Pharmacodynamic target attainment of oral beta-lactams for the empiric treatment of acute otitis media in childrenRenee M Fallon, Joseph L Kuti, Gary V Doern, et al.
Antimicrobial Agents and Chemotherapy|November 3, 2020
Impact of Intraoperative Cell Salvage on Concentrations of Antibiotics Used for Surgical ProphylaxisMaxwell J Lasko, Allison M Conelius, Oscar K Serrano, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 14, 2018
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administrationTomefa E Asempa, Lindsay M Avery, James M Kidd, et al.
Microbiology Spectrum|December 3, 2025
Clinical impact of BioFire Blood Culture Identification 2 implementation in patients with <i>Staphylococcus</i> bacteremiaColin H Duell, Tyler Ackley, Kristin E Linder, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2012
Pharmacokinetics of intravenous linezolid in moderately to morbidly obese adultsAmira A Bhalodi, Pavlos K Papasavas, Darren S Tishler, et al.
Critical Care Medicine|March 27, 2013
Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy culturesKirthana Raman, Michael D Nailor, David P Nicolau, et al.
Clinical Therapeutics|January 2, 2018
Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site AdministrationJames M Kidd, Lindsay M Avery, Tomefa E Asempa, et al.
Journal of Comparative Effectiveness Research|November 1, 2022
Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomesWilliam L Herring, Ian Gopal Gould, Villum Wittrup-Jensen, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2022
Omadacycline pharmacokinetics and soft-tissue penetration in diabetic patients with wound infections and healthy volunteers using in vivo microdialysisChristian M Gill, Andrew J Fratoni, Ashley K Shepard, et al.
Clinical Therapeutics|June 29, 2019
A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Resistant EnterobacteralesTomefa E Asempa, Joseph L Kuti, Julie D Seroogy, et al.
Pageof 60

Showing results (371-380 of 596) with videos related to

Sort By:
Pageof 60
Paediatric Drugs|August 30, 2008
Pharmacodynamic target attainment of oral beta-lactams for the empiric treatment of acute otitis media in childrenRenee M Fallon, Joseph L Kuti, Gary V Doern, et al.
Antimicrobial Agents and Chemotherapy|November 3, 2020
Impact of Intraoperative Cell Salvage on Concentrations of Antibiotics Used for Surgical ProphylaxisMaxwell J Lasko, Allison M Conelius, Oscar K Serrano, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 14, 2018
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administrationTomefa E Asempa, Lindsay M Avery, James M Kidd, et al.
Microbiology Spectrum|December 3, 2025
Clinical impact of BioFire Blood Culture Identification 2 implementation in patients with <i>Staphylococcus</i> bacteremiaColin H Duell, Tyler Ackley, Kristin E Linder, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2012
Pharmacokinetics of intravenous linezolid in moderately to morbidly obese adultsAmira A Bhalodi, Pavlos K Papasavas, Darren S Tishler, et al.
Critical Care Medicine|March 27, 2013
Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy culturesKirthana Raman, Michael D Nailor, David P Nicolau, et al.
Clinical Therapeutics|January 2, 2018
Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site AdministrationJames M Kidd, Lindsay M Avery, Tomefa E Asempa, et al.
Journal of Comparative Effectiveness Research|November 1, 2022
Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomesWilliam L Herring, Ian Gopal Gould, Villum Wittrup-Jensen, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2022
Omadacycline pharmacokinetics and soft-tissue penetration in diabetic patients with wound infections and healthy volunteers using in vivo microdialysisChristian M Gill, Andrew J Fratoni, Ashley K Shepard, et al.
Clinical Therapeutics|June 29, 2019
A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Resistant EnterobacteralesTomefa E Asempa, Joseph L Kuti, Julie D Seroogy, et al.
Pageof 60